Medication info
Rosuvastatin Calcium/Ezetimibe Tablet 10/10 mg

Rosuvastatin Calcium/Ezetimibe Tablet 10/10 mg

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Yuhan Corporation
Appearance
Yellow oblong film-coated tablet
Packaging
30 tablets (10 tablets/PTP × 3), 100 tablets/bottle
Approval status
Active

MFDS item code 201600317 · Approved 2016.01.19 · Insurance code 642104820

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL-cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range of this medicine is 10/5mg∼10/20mg once daily. The recommended initial dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL-cholesterol. After starting this medicine or adjusting the dose, check blood lipid levels after an interval of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Yuhan Corporation

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia
View approved original text

This drug is used to improve cholesterol and lipid levels in patients with primary hypercholesterolemia, particularly heterozygous familial and non-familial hypercholesterolemia or mixed dyslipidemia. It decreases total cholesterol, LDL cholesterol, Apo B, triglycerides, and non-HDL cholesterol, while increasing HDL cholesterol to help vascular health. This drug is used in conjunction with an appropriate diet and is prescribed when dietary control and non-drug therapies are insufficient. Additionally, secondary causes of dyslipidemia should be identified, and treatment should be implemented if necessary. This helps reduce the risk of atherosclerotic vascular disease due to hypercholesterolemia and improves overall blood lipid status.

How to take

Adult dose

This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL-cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range of this medicine is 10/5mg∼10/20mg once daily. The recommended initial dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL-cholesterol. After starting this medicine or adjusting the dose, check blood lipid levels after an interval of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Precautions

This drug may carry a risk of muscle abnormalities, so immediate medical attention should be sought if serious muscle pain or weakness occurs. In particular, if severe infections, hypotension, major surgery or trauma, or hypothyroidism are present, the use of this drug may need to be temporarily stopped or discontinued. Patients with allergies to any components of this drug, severely impaired liver or kidney function, pregnant women, or nursing women should not use this drug. Additionally, caution is required if there is a history of muscle disease or if this drug is used in conjunction with certain medications. Liver function and muscle status should be regularly monitored during treatment, and if there are significant increases in liver enzyme levels or worsening of muscle-related abnormal symptoms, dosing should be discontinued. Patients with a history of alcohol abuse or liver disease, the elderly, and those taking certain medications should use this drug carefully. This drug can rarely cause serious skin reactions or severe muscle weakness, so medical consultation should be sought immediately if skin rashes or muscle weakness occur. Pregnant or nursing women should not use this drug, and women of childbearing age should ensure effective contraception during treatment. Safety in children and adolescents has not been sufficiently confirmed, so it is not recommended. This drug may interact with other medications, so it is essential to inform your doctor or pharmacist of any other medications being taken. In cases of overdose, as there is no specific antidote, appropriate treatment and monitoring based on symptoms are necessary. This drug should be kept out of the reach of children and should not be transferred to other containers.

Side effects

nasopharyngitis, dyspepsia, elevated ALT, edema, myalgia, elevated AST, headache, acute pyelonephritis, dry mouth, elevated liver enzymes, abnormal liver function tests, increased blood lactate dehydrogenase, pruritus, upper respiratory infection, elevated blood glucose, increased blood CPK, chest discomfort, angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia and systemic symptom drug reaction syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, pharyngitis, sinusitis, chest pain, fatigue, bloating, nausea, elevated AST, increased CK, cholelithiasis, cholecystitis, tremor, upper abdominal pain, vomiting, gastritis, dry mouth, epigastric discomfort, belching, gastrointestinal disorder, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, runny nose, limb pain, increased blood creatinine, elevated blood pressure, increased blood urea, muscle cramps, gout, erectile dysfunction, syncope, generalized pain

Not everyone experiences these, and they can vary from person to person.

Storage

This drug may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Yellow oblong film-coated tablet

Package unit

30 tablets (10 tablets/PTP × 3), 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.